- Home
- NUVB vs VMEO Comparison
NUVB vs VMEO Comparison
Compare NUVB & VMEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- VMEO
- Stock Information
- Founded
- NUVB 2018
- VMEO 2004
- Country
- NUVB United States
- VMEO United States
- Employees
- NUVB N/A
- VMEO N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- VMEO Computer Software: Prepackaged Software
- Sector
- NUVB Health Care
- VMEO Technology
- Exchange
- NUVB Nasdaq
- VMEO Nasdaq
- Market Cap
- NUVB 679.9M
- VMEO 668.9M
- IPO Year
- NUVB N/A
- VMEO N/A
- Fundamental
- Price
- NUVB $2.09
- VMEO $3.93
- Analyst Decision
- NUVB Strong Buy
- VMEO Buy
- Analyst Count
- NUVB 6
- VMEO 4
- Target Price
- NUVB $7.83
- VMEO $7.35
- AVG Volume (30 Days)
- NUVB 8.9M
- VMEO 1.7M
- Earning Date
- NUVB 08-04-2025
- VMEO 08-04-2025
- Dividend Yield
- NUVB N/A
- VMEO N/A
- EPS Growth
- NUVB N/A
- VMEO N/A
- EPS
- NUVB N/A
- VMEO 0.10
- Revenue
- NUVB $10,957,000.00
- VMEO $415,130,000.00
- Revenue This Year
- NUVB $101.21
- VMEO $3.90
- Revenue Next Year
- NUVB $410.28
- VMEO $6.17
- P/E Ratio
- NUVB N/A
- VMEO $38.56
- Revenue Growth
- NUVB N/A
- VMEO N/A
- 52 Week Low
- NUVB $1.54
- VMEO $3.45
- 52 Week High
- NUVB $3.97
- VMEO $7.90
- Technical
- Relative Strength Index (RSI)
- NUVB 51.54
- VMEO 32.47
- Support Level
- NUVB $1.87
- VMEO $3.85
- Resistance Level
- NUVB $2.10
- VMEO $4.08
- Average True Range (ATR)
- NUVB 0.16
- VMEO 0.12
- MACD
- NUVB 0.01
- VMEO 0.00
- Stochastic Oscillator
- NUVB 91.23
- VMEO 16.00
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
About VMEO Vimeo Inc.
Vimeo Inc is the all-in-one video software solution, providing the full breadth of video tools through a software-as-a-service model. The comprehensive and cloud-based tools of the company empower its users to create, share, collaborate and communicate with video on a single, turnkey platform. The company derives its revenue from SaaS subscription fees paid by customers for subscription plans.